world
UK Covid-19 Inquiry Publishes Fourth Report, Praising Vaccine Effectiveness and Recommending Compensation Reforms
The UK Covid-19 public inquiry published its fourth report on vaccines and therapeutics, highlighting the success of the vaccination program and recommending urgent reforms to the Vaccine Damage Payment Scheme. The report emphasizes the need for increased payouts and changes to eligibility criteria for those injured by vaccines.
BB
SK
Substrate placeholder — needs reviewAudio version
Tap play to generate a narrated version.
The UK Covid-19 public inquiry published its fourth report into vaccines and therapeutics on Thursday, detailing the impact of the vaccination program during the pandemic. The report is a 274-page study that underscores the effectiveness of Covid-19 vaccines, which, by March 2023, had saved 475,000 lives in England and Scotland.
Baroness Heather Hallett, chair of the inquiry, stated that the Covid-19 vaccine program in the UK was an extraordinary feat and positioned the country as a world leader in biomedical sciences.
She noted that effective systems were in place to assess the safety and efficacy of Covid-19 vaccines, including rigorous trials and regulatory approval processes. In her recommendations, Baroness Hallett urged for urgent reform of the Vaccine Damage Payment Scheme, advocating for an increase in the maximum payouts from the current upper limit of £120,000 to at least £200,000.
She also recommended scrapping the 60% disability threshold for receiving payments and suggested consideration of a graduated threshold scheme.
Baroness Hallett emphasized that the risks associated with Covid-19 vaccines were carefully managed and outweighed by the benefits. Members of clinically vulnerable families welcomed the findings of the report, which highlighted the rapid development and delivery of effective vaccines to the majority of the UK population in record time.
